# Vascugen, Inc. — Form D

Vascugen, Inc. of MADISON, WI, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-24. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-08-24
- Form: D
- Accession: 0001822206-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 6
- Date of first sale: 2019-10-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-373891

## Issuer

- Name: Vascugen, Inc.
- CIK: 0001822206
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 5602 RESEARCH PARK BLVD., MADISON, WI, 53719
- Phone: 6085145564

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Carter Cliff | Director | Cambridge, MA |
| Jeffrey Kennedy | Director | Madison, WI |
| Tom Novak | Director | Madison, WI |
| Marvin Yoder | Director | Madison, WI |
| Carter Cliff | Executive Officer | Cambridge, MA |

## More

- [CIK 1822206 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1822206&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001822206-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.